CN218685686U - Reinforced catheter - Google Patents
Reinforced catheter Download PDFInfo
- Publication number
- CN218685686U CN218685686U CN202221662528.1U CN202221662528U CN218685686U CN 218685686 U CN218685686 U CN 218685686U CN 202221662528 U CN202221662528 U CN 202221662528U CN 218685686 U CN218685686 U CN 218685686U
- Authority
- CN
- China
- Prior art keywords
- catheter
- pipe
- tube
- section
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000009792 diffusion process Methods 0.000 claims abstract description 39
- 238000009941 weaving Methods 0.000 claims abstract description 39
- 239000000463 material Substances 0.000 claims description 44
- 239000004952 Polyamide Substances 0.000 claims description 29
- 229920002647 polyamide Polymers 0.000 claims description 29
- -1 polytetrafluoroethylene Polymers 0.000 claims description 27
- 239000002861 polymer material Substances 0.000 claims description 25
- 239000004814 polyurethane Substances 0.000 claims description 24
- 229920002614 Polyether block amide Polymers 0.000 claims description 23
- 229920001400 block copolymer Polymers 0.000 claims description 21
- 229920002635 polyurethane Polymers 0.000 claims description 21
- 238000000576 coating method Methods 0.000 claims description 13
- 239000011248 coating agent Substances 0.000 claims description 12
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 12
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 12
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 12
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 11
- 229920002674 hyaluronan Polymers 0.000 claims description 11
- 229960003160 hyaluronic acid Drugs 0.000 claims description 11
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 11
- 229920000098 polyolefin Polymers 0.000 claims description 11
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 11
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 11
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 claims description 10
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 claims description 8
- 239000004743 Polypropylene Substances 0.000 claims description 7
- 229920006231 aramid fiber Polymers 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 7
- 239000007769 metal material Substances 0.000 claims description 7
- 229920001155 polypropylene Polymers 0.000 claims description 7
- 210000001503 joint Anatomy 0.000 claims description 6
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 claims description 6
- 239000004698 Polyethylene Substances 0.000 claims description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052737 gold Inorganic materials 0.000 claims description 5
- 239000010931 gold Substances 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- 238000005530 etching Methods 0.000 claims description 4
- 150000002825 nitriles Chemical class 0.000 claims description 4
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 4
- 239000004632 polycaprolactone Substances 0.000 claims description 4
- 229920001610 polycaprolactone Polymers 0.000 claims description 4
- 239000004626 polylactic acid Substances 0.000 claims description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 3
- 229920000271 Kevlar® Polymers 0.000 claims description 3
- 239000004696 Poly ether ether ketone Substances 0.000 claims description 3
- 229920000954 Polyglycolide Polymers 0.000 claims description 3
- 229910000416 bismuth oxide Inorganic materials 0.000 claims description 3
- TYIXMATWDRGMPF-UHFFFAOYSA-N dibismuth;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Bi+3].[Bi+3] TYIXMATWDRGMPF-UHFFFAOYSA-N 0.000 claims description 3
- 229920001903 high density polyethylene Polymers 0.000 claims description 3
- 239000004700 high-density polyethylene Substances 0.000 claims description 3
- 239000004761 kevlar Substances 0.000 claims description 3
- 229920002530 polyetherether ketone Polymers 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 229910052721 tungsten Inorganic materials 0.000 claims description 3
- 239000010937 tungsten Substances 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 238000012800 visualization Methods 0.000 claims 2
- 230000003014 reinforcing effect Effects 0.000 abstract description 13
- 238000005452 bending Methods 0.000 abstract description 3
- 239000010410 layer Substances 0.000 description 124
- 238000003466 welding Methods 0.000 description 18
- 238000010438 heat treatment Methods 0.000 description 13
- 238000004804 winding Methods 0.000 description 11
- 239000002356 single layer Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 230000007704 transition Effects 0.000 description 7
- PEVRKKOYEFPFMN-UHFFFAOYSA-N 1,1,2,3,3,3-hexafluoroprop-1-ene;1,1,2,2-tetrafluoroethene Chemical compound FC(F)=C(F)F.FC(F)=C(F)C(F)(F)F PEVRKKOYEFPFMN-UHFFFAOYSA-N 0.000 description 6
- 229910000566 Platinum-iridium alloy Inorganic materials 0.000 description 6
- 238000009954 braiding Methods 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 5
- 238000001125 extrusion Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000004417 polycarbonate Substances 0.000 description 4
- 229920000515 polycarbonate Polymers 0.000 description 4
- 238000003618 dip coating Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000007917 intracranial administration Methods 0.000 description 3
- 230000002787 reinforcement Effects 0.000 description 3
- 206010002329 Aneurysm Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000010109 chemoembolization Effects 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229920006147 copolyamide elastomer Polymers 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000013151 thrombectomy Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
Images
Landscapes
- Media Introduction/Drainage Providing Device (AREA)
- Materials For Medical Uses (AREA)
Abstract
The utility model relates to the field of medical equipment, a reinforcing pipe is provided, include: a catheter hub; the diffusion stress pipe is connected with one end of the conduit seat; the pipe main part includes inlayer pipe, intermediate level and the outer pipe that sets gradually by interior to exterior, the pipe main part sets up diffusion stress pipe keeps away from the one end of pipe seat, the one end that diffusion stress pipe is close to the pipe main part adopts spiral or interval fretwork design, the intermediate level is including keeping away from section and the helical spring section of weaving that diffusion stress pipe direction set gradually. The utility model discloses have better nature controlled and trafficability characteristic, still have fine compliance and security. The diffusion stress tube and the catheter main body which are specially designed are adopted, so that the damages such as bending of the proximal end of the catheter can be effectively reduced, and the catheter main body can have a smaller passing outer diameter and a larger inner cavity.
Description
Technical Field
The utility model relates to the field of medical equipment, in particular to reinforcing pipe.
Background
Common vascular diseases include ischemic stenosis and hemorrhagic aneurysm. With the popularization of minimally invasive interventional medicine, the improvement of medical instrument technology and the improvement of national consciousness, the advantages of small wound, short operation time, quick postoperative recovery, low operation risk and cost and the like, the minimally invasive intervention gradually replaces the traditional surgical operation and is developed rapidly. The products such as catheters, guide wires, balloons, stents and the like in the process of minimally invasive intervention surgery cover most of the interventional or implanting instruments in the surgery. With the aid of medical imaging equipment, a blood vessel access is established through arterial or venous puncture, and the device is delivered to a target blood vessel position, so that the expansion of clinical common blood vessel stenosis, the removal of thrombus, the treatment of aneurysm occlusion and other diseases are finally realized.
Patent publication No. CN107376101A describes a microcatheter for Transcatheter Arterial Chemoembolization (TACE), the catheter comprising a tube holder, a diffusion stress tube, a tube body, and a tip; the diffusion stress pipe is sleeved outside the joint of the pipe seat and the pipe body and is fixed with the pipe seat in an inverted buckling mode; the pipe body comprises an inner liner, a reinforcing layer and an outer sleeve layer; the reinforcing layer includes a braided section, an overlapping section, and a helical section. Wherein the weaving section is close to the tube seat, the spiral section is close to the head end, and the lap joint section is positioned between the weaving section and the spiral section; the spiral section adopts a structure that a single spiral wire is made into a spiral spring. The patent describes microcatheters having both good pushability and good compliance and passability, while the tip has good shape retention capability. However, the distal end of the catheter is designed only by adopting a single spiral structure, so that the distal end of the catheter is easy to deform at the head end with tortuous lesion and loses the shape-retaining capability. The micro catheter is not provided with the reinforcing wire in the axial direction of the catheter, so that the control capability of the proximal end of the catheter and the tensile resistance of the distal end of the catheter are low, and the effectiveness and the safety of the catheter in clinical use are influenced. The braided section and the spiral section adopt a 'lap joint' mode, so that the outer diameter of a lap joint part is larger, the transmission of the force at the near end of the catheter and the integral passing performance of the catheter are influenced, and even the separation of an inner layer pipe and an outer layer pipe at the lap joint point is caused, so that the safety is influenced.
Patent publication No. CN109498957A describes a novel microcatheter, which comprises a head end, a tube body, a diffusion stress tube and a needle seat arranged in sequence from a distal end to a proximal end, wherein: the head end is doped with developing materials, and a developing ring is arranged between the head end and the tube body; the pipe body sequentially comprises an outer sleeve layer, a woven reinforcing layer, a woven layer and an inner liner layer from outside to inside; and the near end of the tube body is fixedly connected with the needle seat, and the joint of the near end of the tube body and the needle seat is sleeved with the diffusion stress tube. The novel microcatheter described in this patent has strong pushing, bending and tracking properties, while the catheter becomes stiffer from the distal end to the proximal end, thus ensuring distal compliance and shape retention. Publication No. CN108904007A describes an intracranial support catheter, comprising a tube for constructing an intracranial thrombectomy channel, the tube comprising an inner liner and an outer shell, one section of the tube being a reinforcing section, at least two layers of reinforcing layers being arranged between the inner liner and the outer shell, at least one layer being a helical coil structure, and at least one layer being a mesh structure. The patent describes an intracranial support catheter that achieves good kink resistance and significant pushability through improvements in the stiffening layer.
The whole body of the publication No. CN109498957A adopts a braided structure design, and in the patent CN108904007A, the middle layer adopts a structure design with more than two layers. The requirements of the clinical far-end tensile resistance and the near-end manipulation performance are seemingly solved, but the intermediate layer of the two structural designs can cause the increase of the whole outer diameter of the catheter and influence the trafficability characteristic. The knitting of distal end and weave and add the design of helical spring structure can influence its compliance, reduce its ability through pathological change, make sharp-end hardness increase, improved the risk of damage blood vessel inner wall. Although the distal end is made of a material with lower hardness, the bonding performance of the soft material and the inner layer tube of the catheter is reduced due to the adoption of a braided structure, so that the distal end of the catheter is easily layered, and the safety and the effectiveness of the catheter are affected.
Although a plurality of catheter products are used clinically, most of the catheter products have some defects, and the requirements on the comprehensive performances such as the safety, the effectiveness and the like of the catheter in the operation process cannot be effectively met. In the operation process, the near end of the catheter needs to have good controllability, so that the near end force is effectively transferred to the far end force, and the far end of the catheter needs to have good flexibility, so that the catheter is easier to pass through tortuous lesions, and the damage of the head end to the inner wall of the blood vessel is reduced to the maximum extent.
Disclosure of Invention
The utility model provides a reinforcing pipe has better nature controlled and trafficability characteristic, still has fine compliance and security simultaneously. In order to solve the technical problem, the utility model provides a reinforcing pipe, include:
a catheter hub;
the diffusion stress pipe is connected with one end of the conduit seat;
the catheter main body comprises an inner layer pipe, a middle layer and an outer layer pipe which are sequentially arranged from inside to outside, and the catheter main body is arranged at one end, away from the catheter seat, of the diffusion stress pipe.
Optionally, one end of the diffusion stress tube close to the catheter main body is designed to be spiral or hollow at intervals.
Optionally, the diffusion stress tube is made of one of the following materials: polyurethane, polyolefin, polyamide or silicone.
Optionally, the inner layer tube material is a polymer material; the high polymer material is one or more of the following materials: etching polytetrafluoroethylene, high density polyethylene, polyamide or polyetheramide block copolymers; when the high polymer material is one, the polyamide or polyether amide segmented copolymer contains a lubricating material; or when the high polymer material is multiple, the double-layer pipe is composed of etched polytetrafluoroethylene, high-density polyethylene and/or polyamide block copolymer.
Optionally, the intermediate layer includes a braided section and a helical spring section sequentially arranged away from the direction of the diffusion stress tube.
Optionally, the intermediate layer is a metal material, and the metal material is one or more of the following materials: stainless steel, nitinol, platinum iridium, tungsten, or gold;
or, the intermediate layer is made of a high polymer material, and the high polymer material is one or more of the following materials: polyamide, polylactic acid, polypropylene, polyethylene, aramid fiber, kevlar fiber, polypropylene mesh nitrile fiber, polycaprolactone, polyglycolide or polyether ether ketone;
or the intermediate layer is formed by combining a metal material and a high polymer material, and the metal material is one or more of the following materials: stainless steel, nickel-titanium alloy, platinum-iridium alloy, tungsten or gold, wherein the high polymer material is one or more of the following materials: polyamide, polylactic acid, polypropylene, polyethylene, aramid fiber, kevlar fiber, polypropylene mesh nitrile fiber, polycaprolactone, polyglycolide or polyether ether ketone.
Optionally, the intermediate layer is implemented by weaving: the high polymer material is woven by single-strand and/or multi-strand silk materials;
and/or the middle layer realizes the wire formed by the metal material and/or the high polymer material in a spiral spring mode.
Optionally, one end of the catheter main body, which is far away from the diffusion stress tube, is further provided with a developing section, and the developing section is designed by adopting a hollow metal ring or a spiral spring.
Optionally, the outer tube is made of 5-15 polymer materials with different hardness, the polymer materials comprise a plurality of polyamide, polyether amide block copolymer, polyurethane, polyolefin or developing materials, and the hardness of the outer tube is gradually reduced towards the direction far away from the diffusion stress tube.
Optionally, the developing material comprises one or more of the following materials: barium sulfate, bismuth oxide or tungsten powder;
and/or the Shore hardness range of the outer layer tube material at one end far away from the diffusion stress tube is 40-85A;
and/or the addition amount of the developing material is in the range of 30-50 wt%;
and/or the combination mode of the materials with different hardness of the outer layer pipe is seamless butt joint;
and/or the combination mode of the inner layer pipe, the middle layer and the outer layer pipe is thermal shrinkage welding and/or co-extrusion;
and/or the surface of the outer pipe contains a hydrophilic coating, and the hydrophilic coating is polyvinylpyrrolidone and/or hyaluronic acid;
and/or the outer diameter of the catheter main body ranges from 0.30 mm to 3.00mm, and the inner diameter ranges from
0.20-2.30mm。
The utility model has the advantages that: has better control and passing performance, and also has good flexibility and safety. The diffusion stress tube and the catheter main body which are specially designed are adopted, so that the damages such as bending of the proximal end of the catheter can be effectively reduced, and the catheter main body can have a smaller passing outer diameter and a larger inner cavity.
Drawings
FIG. 1 is a schematic view of the overall construction of a reinforced catheter;
FIGS. 2 (a) and 2 (b) are schematic structural views of a diffusion stressed tube in a reinforced conduit;
FIG. 3 (a), FIG. 3 (b), FIG. 3 (c) and FIG. 3 (d) are schematic structural views of an intermediate layer in a reinforcement catheter;
FIGS. 4 (a) and 4 (b) are schematic views of the braid structure of the intermediate layer braid segment of the reinforcement catheter;
FIG. 5 (base:Sub>A), FIG. 5 (b), FIG. 5 (c) and FIG. 5 (d) are schematic views of the cross-sectional structure A-A of the proximal braided section of the intermediate layer of the stiffening catheter;
FIG. 6 (a), FIG. 6 (B), FIG. 6 (c) and FIG. 6 (d) are schematic B-B cross-sectional views of the distal spring segment of the intermediate layer of the reinforcing catheter;
FIGS. 7 (a) and 7 (b) are schematic structural views of the distal hollow development ring of the middle layer of the reinforcing catheter;
FIG. 8 is a schematic structural view of a reinforcing catheter intermediate layer distal developing coil;
fig. 9 (a) and 9 (b) are schematic cross-sectional C-C structures of inner tubes in a reinforcement catheter.
Wherein the figures of the drawings are numbered as follows:
1-a catheter hub; 2-diffusion stress tube; 3-a catheter body; 4-inner layer tube; 5-an intermediate layer; 6-outer layer tube;
7-a hydrophilic coating; 8-weaving section; 9-a helical spring section; 10-development stage.
Detailed Description
The technical solutions in the embodiments of the present invention will be described clearly and completely with reference to the accompanying drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only some embodiments of the present invention, not all embodiments. Based on the embodiments in the present invention, all other embodiments obtained by a person skilled in the art without creative work belong to the protection scope of the present invention.
As shown in fig. 1-9, the present embodiment provides a reinforced catheter, which includes a catheter hub 1, a diffusive stress tube 2 and a catheter body 3. The catheter body 3 is composed of an inner tube 4, an intermediate layer 5, an outer tube 6 and a hydrophilic coating 7. Wherein the intermediate layer 5 consists of a braiding section 8, a helical spring section 9 and a developing section 10. The outer diameter of the catheter is in the range of 0.30-3.00mm, and the inner diameter of the catheter is in the range of 0.20-2.30mm. The catheter main body 3 comprises an inner layer pipe 4, a middle layer 5 and an outer layer pipe 6 which are sequentially arranged from inside to outside, and the catheter main body 3 is arranged at one end, far away from the catheter seat 1, of the diffusion stress pipe 2. The middle layer 5 comprises a braided section 8 and a spiral spring section 9 which are sequentially arranged in the direction away from the diffusion stress pipe 2. The one end that pipe main part 3 kept away from diffusion stress tube 2 still is provided with development section 10, development section 10 adopts fretwork becket or coil spring design.
The utility model adopts the above embodiment have better nature controlled and trafficability characteristic, and the design of diffusion stress pipe and catheter main body can effectively reduce the damage such as buckling of pipe near-end, can make the catheter main body have less external diameter and great inner chamber of passing through moreover.
The following describes how the various modules or components described above may be implemented:
example 1
The catheter base 1 in this embodiment is made of medical Polycarbonate (PC), and the diffusion stress tube 2 is made of a Polyurethane (PU) spiral hollow structure design a (see fig. 2 (b)), and is fixed to the catheter base 1 in an inverted manner. The inner layer tube 4 adopts single-layer etching polytetrafluoroethylene (e-PTFE), and the wall thickness of a single side is 0.02mm. The braiding section 8 of the middle layer adopts 16 strands of 0.002in round wires, variable-density braiding is carried out according to a one-over-one braiding mode, the variation range of the braiding density PPI from the near end to the far end of the catheter is 80-120, and the braiding density of the near end is larger than that of the far end. The spiral spring section 9 adopts a nickel titanium flat wire with the thickness of 0.001 multiplied by 0.005in to carry out variable density single-layer spring winding, the variation range of the spring distance from the near end to the far end of the catheter is 2-5 times of the width of the flat wire, the spring distance of the near end is smaller than that of the far end, and the length of the spiral spring section is 20cm. The tip of one end of the catheter main body 3, which is far away from the diffusion stress tube 2, adopts a developing section 10 with the length of 0.7mm and the regular hollow design, for example, a developing ring. The polymer material can adopt polylactic acid, the monofilament diameter is 0.01mm, the mode of 30 strands of gapless parallel tows is adopted, the polymer tows penetrate through the whole body of the catheter and can be embedded with the wall thickness of the outer layer pipe 6, the outer diameter of the catheter main body 3 cannot be increased, and the axial peak tension of the catheter main body 3 can be greatly improved. Two ends of the weaving section 8 are heated, and two ends of the spiral spring section 9 are fixed in a laser welding mode. The outer layer tube 6 is formed by 7 high polymer materials with different hardness in a seamless butt joint mode, and the polyamide, the polyether-amide block copolymer, the polyurethane and the developing material mixture are respectively arranged from the near end to the far end of the catheter body. As an alternative embodiment, the Shore hardness of the polyamide and the polyether amide block copolymer ranges from 35D to 80D, the hardness of the material of the outer layer tube 6 gradually decreases from the proximal end to the distal end, and the hardness is smoothly transited; for example, the shore hardness of the distal polyurethane is 70A, and the barium sulfate content of the imaging material is 40wt%. The outer layer pipe 6 and the inner layer pipe 4 are welded in a thermal shrinkage mode to realize the reflow integrated welding of the outer layer pipe and the inner layer pipe, and a thermal shrinkage pipe made of perfluoro ethylene propylene copolymer (FEP) is adopted in the welding process. The outer surface of the processed catheter main body is dip-coated with a polyvinylpyrrolidone (PVP) coating with a proper length, and the curing is realized through a heating mode.
Example 2
The catheter base 1 in the embodiment adopts medical Polyamide (PA), the diffusion stress tube 2 adopts Polyolefin (PO) regular interval hollow design B, and the diffusion stress tube is fixed with the catheter base 1 in a thermal shrinkage mode. The inner tube 4 is designed to have a double-layer structure, wherein the inner layer is etched polytetrafluoroethylene (e-PTFE), the outer layer is an ether amide block copolymer (PEBAX), and the unilateral wall thickness is 0.025mm. The middle layer weaving section 8 adopts 16 strands of flat wires of 0.001 multiplied by 0.002in, and carries out variable density weaving according to a one-over-one-under weaving mode, the range of the PPI from the near end to the far end of the catheter is 70-110, and the weaving density of the near end is larger than that of the far end. The spiral spring section 9 adopts nickel titanium parallel flat wires of 0.001 multiplied by 0.003in and 0.001 multiplied by 0.002in to perform uniform-pitch single-layer winding, the pitch is 1-3 times of the width of the parallel flat wires, and the length of the spiral spring is 15cm. The developing section 10 adopts a platinum-iridium alloy developing tight spring ring with the length of 1.0mm and the wire diameter of 0.02mm. The diameter of the polycaprolactone monofils is 0.015mm, a mode of 10 gapless side-by-side tows is adopted, and 4 groups of tows penetrate through the whole body of the catheter. The two ends of the braided section 8 are heated, and the two ends of the spiral spring section 9 are fixed by medical instant adhesive. The outer layer tube 6 is formed by seamlessly butting 10 high polymer materials with different hardness, the mixture of polyamide, polyether amide block copolymer, polyurethane and developing material is respectively arranged along the near end to the far end of the catheter, furthermore, the Shore hardness change range of the polyamide and polyether amide block copolymer is 25D-80D, the hardness of the outer layer material of the catheter is gradually reduced from the near end to the far end, and the smooth transition is realized; the Shore hardness of the distal polyurethane is 50A, and the content of barium sulfate in the developing material is 35wt%. The inner layer and the outer layer of the catheter are welded in a thermal shrinkage mode to realize the reflux integrated welding of the outer layer and the inner layer and the outer layer, and a thermal shrinkage pipe made of perfluoroethylene propylene copolymer (FEP) is adopted in the welding process. The outer surface of the processed catheter main body is coated with a Hyaluronic Acid (HA) coating layer with a proper length in a dip-coating mode, and curing is achieved through a heating mode.
EXAMPLE 3
The catheter hub 1 in this example used polyethylene terephthalate-1, 4-cyclohexanedimethanol ester (PCTG). The diffusion stress tube 2 is designed by silica gel (Silicon) at regular intervals in a hollow mode B, and is fixed with the catheter seat 1 in a back-off mode. The inner layer tube 4 adopts etched polytetrafluoroethylene (e-PTFE) of a single-layer silver-plated copper mandrel, and the thickness of a single-side wall is 0.015mm. The middle layer weaving section 8 adopts 8 strands of flat wires of 0.001 multiplied by 0.002in and 8 strands of round wires of 0.002in to carry out mixed variable density weaving according to a one-over-one-under weaving mode, the range of the PPI from the near end to the far end of the catheter is 80-100, and the weaving density of the near end is greater than that of the far end. The spiral spring section 9 adopts a nickel titanium flat wire with the thickness of 0.001 multiplied by 0.005in to carry out variable density single-layer spring winding, the variation range of the spring distance from the near end to the far end of the catheter is 1 to 4 times of the width of the flat wire, the spring distance of the near end is smaller than that of the far end, and the length of the spiral spring is 25cm. The developing section 10 adopts a gold developing tight spring ring with the length of 0.8mm and the wire diameter of 0.03 mm. The diameter of each polypropylene reticular nitrile fiber monofilament is 0.01mm, a mode of 10 gapless side-by-side tows is adopted, and 4 groups of tows are positioned in a spiral spring area at the far end of the catheter. The two ends of the braided section 8 are heated, and the two ends of the spiral spring are fixed by laser welding. The outer layer tube 6 is formed by seamless butt joint of 12 high polymer materials with different hardness, polyamide, polyether amide block copolymer and polyurethane are respectively arranged along the near end to the far end of the catheter, furthermore, the Shore hardness change range of the polyamide and the polyether amide block copolymer is 30D-74D, the hardness of the outer layer material of the catheter is gradually reduced from the near end to the far end, and the smooth transition is realized; the shore hardness of the distal polyurethane was 55A. The inner layer and the outer layer of the catheter are welded in a thermal shrinkage mode to realize the reflux integrated welding of the outer layer and the inner layer and the outer layer, and a thermal shrinkage pipe made of perfluoroethylene propylene copolymer (FEP) is adopted in the welding process. The outer surface of the processed catheter main body is dip-coated with a polyvinylpyrrolidone (PVP) coating with a proper length, and the curing is realized through a heating mode.
Example 4
The catheter base 1 in this embodiment is made of medical Polycarbonate (PC), and the diffusive stress tube 2 is made of Polyolefin (PO) spiral design a (see fig. 2 (a)), and is fixed to the catheter base 1 by heat shrinkage. The inner layer tube 4 is designed by adopting a double-layer structure, wherein the inner layer is etched polytetrafluoroethylene (e-PTFE), the near end of the outer layer is ether amide block copolymer (PEBAX), the far end is Polyurethane (PU), and the unilateral wall thickness of the inner layer tube is 0.023mm. The middle layer weaving section 8 adopts 16 strands of 0.002in round wires, the density-variable weaving is carried out according to the weaving mode of two upper parts and two lower parts, the range of the PPI from the near end to the far end of the catheter is 60-100, and the weaving density of the near end is larger than that of the far end. The spiral spring section 9 adopts a nickel titanium flat wire of 0.001 multiplied by 0.004in to carry out variable density single-layer spring winding, the variation range of the spring distance from the near end to the far end of the catheter is 2 to 3 times of the width of the flat wire, the spring distance of the near end is smaller than that of the far end, and the length of the spiral spring is 18cm. The developing section 10 adopts a hollow platinum-iridium alloy developing ring with the length of 0.8 mm. The diameter of the aramid fiber monofilament is 0.01mm, a mode of 6 strands of gapless side-by-side tows is adopted, and 8 groups of tows penetrate through the whole body of the conduit. Two ends of the weaving section 8 are subjected to heating treatment, and two ends of the spiral spring are fixed by ultraviolet curing glue. The outer layer tube 6 is formed by 15 high polymer materials with different hardness in a seamless butt joint mode, the mixture of polyamide, polyether amide block copolymer, polyurethane and developing materials is respectively arranged along the near end to the far end of the catheter, furthermore, the Shore hardness change range of the polyamide and polyether amide block copolymer is 25D-74D, the hardness of the outer layer material of the catheter is gradually reduced from the near end to the far end, and smooth transition is achieved; the shore hardness of the distal polyurethane is 55A, and the content of the developing material bismuth oxide is 45wt%. The inner layer and the outer layer of the conduit are welded in a thermal shrinkage mode to realize the reflux integrated welding of the outer layer and the inner layer, and a thermal shrinkage pipe made of perfluoroethylene propylene copolymer (FEP) is adopted in the welding process. The outer surface of the processed catheter main body is coated with a Hyaluronic Acid (HA) coating with a proper length in a dip-coating mode, and curing is achieved through a heating mode.
Example 5
The catheter base 1 in the embodiment adopts polyethylene terephthalate-1, 4-cyclohexane dimethanol ester (PCTG), the diffusion stress tube 2 adopts Polyolefin (PO) regular interval hollow design B, and is fixed with the catheter base 1 in an inverted manner. The inner layer tube 4 adopts etched polytetrafluoroethylene (e-PTFE) of a single-layer silver-plated copper mandrel, and the thickness of a single-side wall is 0.01mm. The middle layer weaving section 8 adopts 16 strands of 0.002in round wires and carries out equal-density weaving according to a one-over-one weaving mode. The spiral spring section 9 adopts a nickel titanium flat wire of 0.001 multiplied by 0.005in to perform equal-density single-layer spring winding, the density of the spring winding is 3 to 5 times of the width of the flat wire, and the length of the spiral spring is 30cm. The developing section 10 adopts a hollow platinum-iridium alloy developing ring with the length of 0.8 mm. The diameter of the aramid fiber monofilament is 0.01mm, a mode of 6 strands of gapless side-by-side tows is adopted, and 4 groups of tows penetrate through the whole body of the conduit. Two ends of the weaving section 8 are subjected to heating treatment, and two ends of the spiral spring are fixed by adopting laser tube welding. The outer layer tube 6 is made of 7 high polymer materials with different hardness, polyamide, polyether amide block copolymer and polyurethane are respectively arranged along the near end to the far end of the catheter, furthermore, the Shore hardness change range of the polyamide and polyether amide block copolymer is 25D-72D, the hardness of the outer layer material of the catheter is gradually reduced from the near end to the far end, and the smooth transition is realized; the shore hardness of the distal polyurethane was 45A. The outer layer high polymer material with various hardness is melted, and the inner layer and the outer layer of the catheter are processed through integral continuous co-extrusion through a plurality of groups of co-extrusion machine heads. The outer surface of the processed catheter main body is dip-coated with a polyvinylpyrrolidone (PVP) coating with a proper length, and the curing is realized through a heating mode.
Example 6
The catheter base 1 in the embodiment adopts medical Polyamide (PA), the diffusion stress tube 2 adopts polyurethane (TPU), the regular interval hollow design B is adopted, and the catheter base 1 is fixed in an inverted buckle mode. The inner tube 4 is made of single-layer etched polytetrafluoroethylene (e-PTFE) with a single-side wall thickness of 0.025mm. The middle layer weaving section 8 adopts 16 strands of flat wires of 0.001 multiplied by 0.002in, the density-variable weaving is carried out according to the weaving mode of two strands of flat wires, the range of the PPI from the near end to the far end of the catheter is 70-90, and the weaving density of the near end is larger than that of the far end. The spiral spring section 9 adopts a nickel titanium flat wire of 0.001 multiplied by 0.005in to perform equal-density winding, the density of the winding spring is 1 to 3 times of the width of the flat wire, and the length of the spiral spring is 20cm. The developing section 10 adopts a platinum-iridium alloy developing tight spring ring with the length of 1.0mm and the wire diameter of 0.05 mm. The diameter of the aramid fiber monofilament is 0.005mm, a mode of 20 strands of gapless side-by-side tows is adopted, and 4 groups of tows penetrate through the whole body of the conduit. Two ends of the weaving section 8 are subjected to heating treatment, and two ends of the spiral spring are fixed by adopting laser tube welding. The outer layer tube 6 is made of 10 high polymer materials with different hardness, polyamide, polyether amide block copolymer, polyurethane and a developing material mixture are respectively arranged along the near end to the far end of the catheter, furthermore, the Shore hardness change range of the polyamide and the polyether amide block copolymer is 30D-72D, the hardness of the outer layer material of the catheter is gradually reduced from the near end to the far end, and the smooth transition is realized; the Shore hardness of the far-end polyurethane is 60A, and the content of the tungsten powder of the developing material is 45wt%. The outer layer high polymer material with various hardness is melted, and the inner layer and the outer layer of the catheter are processed through integral continuous co-extrusion through a plurality of groups of co-extrusion machine heads. The outer surface of the processed catheter main body is coated with a Hyaluronic Acid (HA) coating with a proper length in a dip-coating mode, and curing is achieved through a heating mode.
Example 7
The catheter base 1 in the embodiment adopts medical Polycarbonate (PC), the diffusion stress tube 2 adopts polyurethane (TPU), the regular interval hollow design B is adopted, and the back-off mode is adopted to be fixed with the catheter base 1. The inner layer tube 4 adopts single-layer etching polytetrafluoroethylene (e-PTFE), and the wall thickness of a single side is 0.025mm. The middle layer weaving section 8 adopts 16 strands of flat wires of 0.001 multiplied by 0.002in, and carries out variable density weaving according to a one-over-one-under weaving mode, the range of PPI from the near end to the far end of the catheter is 70-110, and the weaving density of the near end is larger than that of the far end. The spiral spring section 9 adopts a nickel titanium flat wire of 0.001 multiplied by 0.005in to carry out equal-density double-spiral winding spring, the density of the winding spring is 1-4 times of the width of the flat wire, and the length of the spiral spring is 25cm. The developing section 10 adopts a gold developing tight spring ring with the length of 1.0mm and the wire diameter of 0.05 mm. The diameter of the aramid fiber monofilament is 0.005mm, a mode of 10 gapless parallel tows is adopted, and 2 groups of tows penetrate through the whole body of the conduit. Two ends of the weaving section 8 are subjected to heating treatment, and two ends of the spiral spring are fixed by adopting laser tube welding. The outer layer tube 6 is made of 8 high polymer materials with different hardness, and is respectively a mixture of polyamide, polyether amide block copolymer, polyurethane and a developing material from the near end to the far end of the catheter, further, the Shore hardness change range of the polyamide and the polyether amide block copolymer is 30D-74D, the hardness of the outer layer material of the catheter is gradually reduced from the near end to the far end, and the smooth transition is realized; the shore hardness of the distal polyurethane is 55A, and the content of barium sulfate in the developing material is 35wt%. The inner layer and the outer layer of the conduit are welded in a thermal shrinkage mode to realize the reflux integrated welding of the outer layer and the inner layer, and a thermal shrinkage pipe made of perfluoroethylene propylene copolymer (FEP) is adopted in the welding process. The outer surface of the processed catheter main body is dip-coated with polyvinylpyrrolidone (PVP) and Hyaluronic Acid (HA) coatings with proper lengths, wherein the hyaluronic acid coating is positioned at a far end and is solidified in a heating mode.
Example 8
The catheter holder 1 in the embodiment adopts medical Polycarbonate (PC), the diffusion stress tube 2 adopts Polyolefin (PO) spiral design A, and is fixed with the catheter holder 1 in a thermal shrinkage mode. The inner layer tube 4 is designed by adopting a double-layer structure, wherein the inner layer is etched polytetrafluoroethylene (e-PTFE), the near end of the outer layer is ether amide block copolymer (PEBAX), the far end is Polyurethane (PU), and the unilateral wall thickness of the inner layer tube is 0.025mm. The middle layer weaving section 8 adopts 16 strands of 0.002in round wires, variable density weaving is carried out according to a one-over-one-under weaving mode, the range of PPI from the near end to the far end of the catheter is 60-100, and the weaving density of the near end is larger than that of the far end. The spiral spring section 9 adopts a nickel-titanium flat wire of 0.001 multiplied by 0.004in to carry out variable-density double-spiral spring winding, the variation range of the spring distance from the near end to the far end of the catheter is 2-5 times of the width of the flat wire, the spring distance of the near end is smaller than that of the far end, and the length of the spiral spring is 30cm. The developing section 10 adopts a hollow platinum-iridium alloy developing ring with the length of 0.8 mm. The diameter of the polyethylene monofilament is 0.01mm, a mode of 6 strands of gapless side-by-side tows is adopted, and 4 groups of tows penetrate through the whole body of the catheter. Two ends of the weaving section 8 are subjected to heating treatment, and two ends of the spiral spring are fixed by ultraviolet curing glue. The outer layer tube 6 is formed by seamless butt joint of 13 high polymer materials with different hardness, polyamide, polyether amide block copolymer and polyurethane are respectively arranged along the near end to the far end of the catheter, furthermore, the Shore hardness change range of the polyamide and polyether amide block copolymer is 25D-74D, the hardness of the outer layer material of the catheter is gradually reduced from the near end to the far end, and smooth transition is realized; the shore hardness of the distal polyurethane was 45A. The inner layer and the outer layer of the catheter are welded in a thermal shrinkage mode to realize the reflux integrated welding of the outer layer and the inner layer and the outer layer, and a thermal shrinkage pipe made of perfluoroethylene propylene copolymer (FEP) is adopted in the welding process. The outer surface of the processed catheter main body is dip-coated with polyvinylpyrrolidone (PVP) with proper length, and the curing is realized through a heating mode.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (10)
1. A reinforced catheter, comprising:
a catheter hub;
the diffusion stress pipe is connected with one end of the conduit seat;
the pipe main part includes inlayer pipe, intermediate level and the outer pipe that sets gradually by interior to exterior, the pipe main part sets up diffusion stress pipe keeps away from the one end of pipe seat, the one end that diffusion stress pipe is close to the pipe main part adopts spiral or interval fretwork design, the intermediate level is including keeping away from section and the helical spring section of weaving that diffusion stress pipe direction set gradually.
2. The reinforced conduit of claim 1 wherein the diffusion stressed tube is one of the following materials: polyurethane, polyolefin, polyamide or silicone.
3. The reinforced conduit of claim 1 or 2, wherein the intermediate layer is a metallic material, the metallic material being one of: stainless steel, nitinol, platinum iridium, tungsten, or gold.
4. The reinforced catheter of claim 1 or 2, wherein the inner layer tube material is a polymeric material; the high polymer material is one of the following materials: etching polytetrafluoroethylene, high density polyethylene, polyamide or polyetheramide block copolymers.
5. The reinforced catheter of claim 1 or 2, wherein the intermediate layer is a polymeric material, the polymeric material being one of the following: polyamide, polylactic acid, polypropylene, polyethylene, aramid fiber, kevlar fiber, polypropylene mesh nitrile fiber, polycaprolactone, polyglycolide or polyether ether ketone.
6. The reinforced conduit according to claim 5, wherein the intermediate layer is woven to: the high polymer material is woven by single-strand and/or multi-strand silk materials.
7. The reinforced catheter of claim 1 or 6, wherein a development section is further arranged at one end of the catheter main body, which is far away from the diffusion stress tube, and the development section is designed by adopting a hollow metal ring or a spiral spring.
8. The reinforced catheter of claim 7, wherein the visualization material of the visualization section comprises one of the following materials: barium sulfate, bismuth oxide or tungsten powder.
9. The reinforced catheter of claim 1 or claim 2, wherein the outer tube has a hydrophilic coating on its surface, the hydrophilic coating being polyvinylpyrrolidone or hyaluronic acid.
10. The reinforced catheter of claim 8, wherein the shore hardness of the outer tube material at the end distal to the diffusively stressed tube is in the range of 40A-85A;
and/or the combination mode of the materials with different hardness of the outer layer pipe is seamless butt joint;
and/or, the outer diameter of the catheter body ranges from 0.30 mm to 3.00mm, and the inner diameter of the catheter body ranges from 0.20 mm to 2.30mm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202221662528.1U CN218685686U (en) | 2022-06-30 | 2022-06-30 | Reinforced catheter |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202221662528.1U CN218685686U (en) | 2022-06-30 | 2022-06-30 | Reinforced catheter |
Publications (1)
Publication Number | Publication Date |
---|---|
CN218685686U true CN218685686U (en) | 2023-03-24 |
Family
ID=85606148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202221662528.1U Active CN218685686U (en) | 2022-06-30 | 2022-06-30 | Reinforced catheter |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN218685686U (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115154865A (en) * | 2022-06-30 | 2022-10-11 | 上海英威思医疗科技有限公司 | Reinforced catheter |
-
2022
- 2022-06-30 CN CN202221662528.1U patent/CN218685686U/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115154865A (en) * | 2022-06-30 | 2022-10-11 | 上海英威思医疗科技有限公司 | Reinforced catheter |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0810003B1 (en) | Kink-resistant braided catheter with distal side holes | |
CA2182526C (en) | High performance braided catheter | |
US6824553B1 (en) | High performance braided catheter | |
JP4009324B2 (en) | Reinforced catheter with a moldable distal tip | |
US6165163A (en) | Soft-tip performance braided catheter | |
JP4213350B2 (en) | Vascular catheter with composite reinforcement | |
EP0930910B1 (en) | Guide catheter with enhanced guidewire tracking | |
US6171295B1 (en) | Intravascular catheter with composite reinforcement | |
EP1551489B1 (en) | Wire braid-reinforced microcatheter | |
EP1583579B1 (en) | Unbalanced reinforcement members for medical device | |
JP2021520858A (en) | Microcatheter | |
CN218420634U (en) | Reinforced catheter with braided middle layer catheter | |
JP2022515796A (en) | New microcatheter | |
CN209884980U (en) | Novel micro-catheter | |
CN218685686U (en) | Reinforced catheter | |
CN218420635U (en) | Reinforcing pipe with interval fretwork formula diffusion stress pipe | |
CN218280297U (en) | Reinforcing pipe with spiral spring intermediate layer pipe | |
CN218420636U (en) | Reinforced catheter with spiral diffusion stress tube | |
CN115154865A (en) | Reinforced catheter | |
CN112221004A (en) | Micro-catheter | |
JP2006333966A (en) | Catheter tube for embolus coil delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant |